MediPal Holdings Corporation (TYO:7459)
Japan · Delayed Price · Currency is JPY 2,670.50
+74.00 (2.85%)
Nov 21, 2025, 3:30 PM JST
MediPal Holdings Revenue
MediPal Holdings had revenue of 952.40B JPY in the quarter ending September 30, 2025, with 4.05% growth. This brings the company's revenue in the last twelve months to 3.74T, up 3.88% year-over-year. In the fiscal year ending March 31, 2025, MediPal Holdings had annual revenue of 3.67T with 3.16% growth.
Revenue (ttm)
3.74T
Revenue Growth
+3.88%
P/S Ratio
0.15
Revenue / Employee
286.67M
Employees
13,061
Market Cap
546.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.67T | 112.60B | 3.16% |
| Mar 31, 2024 | 3.56T | 198.72B | 5.91% |
| Mar 31, 2023 | 3.36T | 69.09B | 2.10% |
| Mar 31, 2022 | 3.29T | 79.80B | 2.48% |
| Mar 31, 2021 | 3.21T | -41.95B | -1.29% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |